How Semantic Knowledge Graph can solve the context challenge in Research and Development
The R&D Data Challenge
In R&D, AI requires context, and right now, context is the biggest challenge in life sciences R&D. Fragmented data, inconsistent terminology, and siloed systems prevent meaningful insights and lack contextual relationships. When diseases, targets, and drugs are not connected, AI hallucinates. But when data becomes structured and contextualized, it can be transformed into operational and true scientific intelligence.
In real terms, why is context so important in R&D? In AI-driven R&D, context is the difference between a breakthrough and a hallucination. For example, if one system records a drug as Paracetamol and another as Acetaminophen, failure to harmonize these terms leads to incomplete insights and unreliable AI outputs and hallucinations.
The Semantic Knowledge Graph: Unlocking the Meaning in Unstructured Data
Currently, the biotech industry generates a quantum of data, most of which is fragmented and lacks context. A semantic knowledge graph can provide a structured backbone required to transform siloed, fragmented data into operational intelligence. It connects complex scientific concepts such as genes, diseases, and therapies within a structured semantic knowledge graph, enabling contextual and evidence-linked nsights.
Knowledge graphs allow AI to interact, reason, validate, and infer valuable, meaningful context beyond the command prompt and process text. From theory to real-world practice, semantic technology enables cross-domain interoperability, predictive analysis, and intelligence that convert raw scientific data into actionable, meaningful insights and breakthroughs. In life sciences R&D, the semantic layer helps to harmonize different facets of biology in the context of disease, therapy, and drug discovery.
BioTech360 simply does that. A semantic-first platform, BioTech360 connects fragmented data, enables contextual insights, accelerates decisions, and simplifies complex scientific data into operational intelligence from ontology-driven searches to drug discovery and regulatory compliance.
Validating and Inferring Knowledge from Ontology
An Ontology is a well-defined, structured model that defines concepts, relationships, and standardized terms and synonyms to establish relationships and share understanding across multiple datasets, tools, and teams within a specific domain, such as biology. An example is Gene Ontology (GO), which specifically classifies gene functions, cellular components, biological processes, and disease relationships.
Ontologies provide mechanistic insights, accelerate hypothesis development, and strengthen evidence-based decision-making in life sciences R&D. They can prevent incorrect conclusions by embedding logical consistency in the workflow.
Semantic Knowledge Graph: An important asset for Agentic AI in Life Sciences
For AI to act as a true autonomous agent, it needs to observe, reason, plan, adapt, and connect all domains of biology to deliver a meaningful outcome to the research team. Traditional relational tables and databases are good at storing rows of data for
structured use; however, the real relationships still remain hidden as they fail to capture and develop meaningful insights for complex biological relationships.
A Semantic knowledge graph can change this by making context explicit, by connecting genes, variants, pathways, biomarkers, lead compounds, and outcomes through semantic relationships and ontology classifications that AI can reason over. This kind of semantic intelligence provides a core autonomic foundation for AI agents.
How Ontology-Driven Semantic Knowledge Graph Works: A Use Case
To provide a scientist in a drug discovery organization with a meaningful, integrated understanding, the knowledge graph must connect all layers of information into a single mechanistic continuum rather than isolated data points.
An example is how Type 2 Diabetes Mellitus (T2DM) can be modeled into a semantic network by mapping layers of information from multiple sources to provide meaningful context for drug discovery.
-
Disease to Molecular Layer
-
Molecular to Diagnostic Layer
-
Diagnostic to Treatment Layer
-
Treatment to Developing New Drug Layer
T2DM is clinically defined by persistent and uncontrolled hyperglycaemia.Semantically, the underlying molecular mechanisms include insulin resistance, β-cell dysfunction, and genetic predispositions related to TCF7L2 and KCNQ1 gene variants.
The molecular layer maps directly into the diagnostic layer by measuring fasting and post-prandial plasma glucose and HbA1c levels. This framework semantically links each diagnostic readout to its underlying pathways and genes, and vice versa, so that the relationship between genetic predisposition and hyperglycaemia becomes apparent.
At the time of T2DM diagnosis, each marker is interpreted in the context of the molecular mechanisms it represents, and by semantically mapping biomarkers to pathways, anti-diabetic therapies are selected.
Here comes the bi-directional flow by going back to gene ontology and understanding molecular mechanisms. By connecting therapies back to pathways, biomarkers, and outcomes, the semantic layer identifies gaps and flags where therapeutic responses and mechanistic gaps are falling short. This holistic approach enables scientists to focus on new targets and new molecular entities.
A workflow depicting how a semantic knowledge graph can be created that can help in translating research from knowledge to bench and bedside.
BioTech360 Delivers Semantic Knowledge Graphs with Value
BioTech 360 is a next-generation semantic intelligence platform that can provide the semantic layer for novel molecular interventions and drug discoveries. It provides a strategic foundation for biotech enterprises seeking to transform scientific and regulatory data into a unified, semantic search framework with cross-domain interoperability and AI-driven analytics. By associating ontology with cross-domain
metadata, the platform can help identify lead candidates for drug discovery and establish direct, data-driven mechanistic insights for scientific validation.
At LabVantage, we help you lay this critical foundation with BioTech360 through our semantic knowledge platform and extend it with AI capabilities that automate reasoning and resonate across your R&D workflows, helping your organization to become not just data-driven, but truly intelligence-ready.
With over 40 years of experience and a pioneer in laboratory informatics, LabVantage enters a new chapter by embedding autonomic intelligence into complex laboratory solutions to infer more meaningful context to your R&D. Discover more by visiting BioTech360 by LabVantage.
